| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |